NIDDK Home : Clinical Trials : Protocol for DPP : Consent Form Step 2

[Name of Institution]
Information and Consent for Screening Step 2
Diabetes Prevention Program (DPP)

Investigators

Name of Principal Investigator
Title, Affiliation, Phone Number

Name of Co-Investigator(s)
Title, Affiliation, Phone Number

Name of Program Coordinator
Title, Affiliation, Phone Number

Name of Recruitment Coordinator
Title, Affiliation, Phone Number

24-Hour Emergency Telephone Number
[List phone number(s) here]

Investigator's Statement

Purpose

This research study is called the Diabetes Prevention Program (DPP). This study will test several ways to prevent the common form of diabetes (type 2 diabetes, also called non-insulin-dependent diabetes mellitus or NIDDM). The purpose of this part of screening for DPP is to find out more about your risk for getting type 2 diabetes by doing an oral glucose tolerance test. If this test shows you have impaired glucose tolerance (also called IGT) and other conditions are met, you will be offered the chance to join DPP.

Benefits

By doing the oral glucose tolerance test, early detection of diabetes is possible. From this test, we will be able to tell whether you have diabetes, IGT, or normal glucose tolerance. You may choose not to find this out by not taking part in this test. If the test suggests that you might have diabetes, you will be referred to a doctor of your choice for treatment. If you do not have a doctor, we will help you to find a doctor for treatment.

Procedures

You will be asked to not eat or drink anything, except water, for 12 hours before your appointment.

1. Height, weight, and blood pressure will be checked (if not done previously). This will take about 10 minutes.

2. A blood sample, about 1 teaspoon, will be taken from your arm and the glucose level measured right away. You will also be asked to give a urine sample. This will take about 15 minutes.

3. Depending upon the level of glucose in this test, an oral glucose tolerance test will be done. Another blood sample, about 2 tablespoons, will be taken from your arm (this might be postponed until a later visit). You will then be asked to drink a glassful of flavored sugar water over 5 to 10 minutes. Another blood sample, about 1 tablespoon, will be taken from your arm at 30 and again at 120 minutes later. This test will take up to 2 and 1/2 hours.

Risks and Discomforts

The risks of drawing blood include temporary discomfort from the needle stick, and possible bruising or redness of the skin. About one out of ten people have mild nausea or an upset stomach with the glucose (sugar) drink that is given during the oral glucose tolerance test. You might feel uncomfortable about some of the questions asked of you. You may choose not to answer any questions.

Other Information

[Institutional language as suggested by your IRB may be substituted for the following sections.]

Information that we get from you will be kept confidential to the extent allowed under law. You are free to take back your consent and stop taking part at any time. You may ask any questions about the study at any time. All study procedures will be free of charge.

If you are hurt as a direct result of the study, medical treatment will be done at no cost within the limits of our compensation plan. Beyond this, treatment will be at your expense or that of your insurance carrier.

If you have any more questions about your rights as a research subject, you may call [name of IRB contact] at [IRB phone number].

 

________________________________________________________________

Investigator's Signature                                                                  Date

 

 

Participant's Statement

The study described above has been explained to me. I understand that I am consenting to participate in this part of the study. If I have any questions about the study, I know that I can contact any of the persons listed on the first page.

 

________________________________________________________________

Participant's Signature                                                                    Date

 

cc: Investigator
  Participant




Some documents are in various format.
* Documents in PDF format require the free Adobe Acrobat Reader exit-disclaimer Icon application for viewing.
* Documents in DOC format require the free MS Word Viewer. exit-disclaimer Icon for excel and powerpoint
* Documents in XLS format require the free Excel Viewer. exit-disclaimer Icon
* Documents in PPT format require the free PowerPoint Viewer. exit-disclaimer Icon

Contact NIDDK |   Privacy Statement |   Disclaimers |  Freedom of Information Act |  For Staff Only |  Accessibility |  Copyright Status |  Archives Site Map                            

Director: Griffin P. Rodgers, M.D., M.A.C.P
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is part of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services.
 
General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
USA
Phone: 301.496.3583